NASDAQ:DOX - Amdocs Stock Price, Forecast & News

Amdocs trades on the NASDAQ under the ticker symbol "DOX."

Amdocs declared a quarterly dividend on Tuesday, November 12th. Stockholders of record on Tuesday, December 31st will be given a dividend of $0.285 per share on Friday, January 24th. This represents a $1.14 annualized dividend and a dividend yield of 1.53%. The ex-dividend date of this dividend is Monday, December 30th. View Amdocs' Dividend History.

Amdocs Limited (NASDAQ:DOX) released its quarterly earnings results on Tuesday, November, 12th. The technology company reported $1.08 earnings per share (EPS) for the quarter, hitting the Thomson Reuters' consensus estimate of $1.08. The technology company earned $1.03 billion during the quarter, compared to analyst estimates of $1.03 billion. Amdocs had a return on equity of 15.98% and a net margin of 11.73%. The firm's revenue for the quarter was up 2.8% compared to the same quarter last year. During the same period in the previous year, the business earned $0.99 EPS. View Amdocs' Earnings History.

Amdocs is scheduled to release their next quarterly earnings announcement on Tuesday, February 4th 2020. View Earnings Estimates for Amdocs.

Amdocs will be holding an earnings conference call on Tuesday, February 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Amdocs updated its first quarter 2020 After-Hours earnings guidance on Monday, November, 25th. The company provided EPS guidance of $1.02-1.08 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.11. The company issued revenue guidance of $$1.015-1.055 billion, compared to the consensus revenue estimate of $$1.04 billion.

3 analysts have issued 12-month target prices for Amdocs' shares. Their forecasts range from $72.00 to $83.00. On average, they expect Amdocs' share price to reach $76.67 in the next twelve months. This suggests a possible upside of 3.1% from the stock's current price. View Analyst Price Targets for Amdocs.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amdocs in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Amdocs.

News articles about DOX stock have been trending positive on Monday, InfoTrie reports. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Amdocs earned a media sentiment score of 3.0 on InfoTrie's scale. They also gave media headlines about the technology company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Amdocs.

Amdocs saw a increase in short interest in the month of December. As of December 31st, there was short interest totalling 3,170,000 shares, an increase of 6.4% from the December 15th total of 2,980,000 shares. Based on an average trading volume of 660,900 shares, the days-to-cover ratio is presently 4.8 days. Approximately 2.4% of the shares of the stock are sold short. View Amdocs' Current Options Chain.

Some companies that are related to Amdocs include Accenture (ACN), IBM (IBM), Cognizant Technology Solutions (CTSH), Leidos (LDOS), Gartner (IT), EPAM Systems (EPAM), Booz Allen Hamilton (BAH), Caci International (CACI), Mantech International (MANT), Teradata (TDC), Virtusa (VRTU), Forrester Research (FORR), Unisys (UIS), The Hackett Group (HCKT) and Servicesource International (SREV).

Based on aggregate information from My MarketBeat watchlists, some companies that other Amdocs investors own include Home Depot (hd), Comcast (CMCSA), QUALCOMM (QCOM), Target (TGT), Activision Blizzard (ATVI), AbbVie (ABBV), Boeing (BA), Caterpillar (CAT), Delta Air Lines (DAL) and Iqvia (IQV).

Amdocs' stock is owned by a variety of of retail and institutional investors. Top institutional investors include PGGM Investments (0.34%), Boston Trust Walden Corp (0.15%), State of Alaska Department of Revenue (0.06%), Bowling Portfolio Management LLC (0.02%), Assenagon Asset Management S.A. (0.02%) and CenturyLink Investment Management Co (0.01%).

DOX stock was sold by a variety of institutional investors in the last quarter, including PGGM Investments, Boston Trust Walden Corp, Douglass Winthrop Advisors LLC, CenturyLink Investment Management Co, Henry James International Management Inc., First Hawaiian Bank, Wedge Capital Management L L P NC and Bowling Portfolio Management LLC.

DOX stock was bought by a variety of institutional investors in the last quarter, including Orrstown Financial Services Inc., Assenagon Asset Management S.A., State of Alaska Department of Revenue, We Are One Seven LLC, OLD National Bancorp IN, Cerebellum GP LLC, Accurate Investment Solutions Inc. and Raymond James Trust N.A..

Shares of DOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of DOX stock can currently be purchased for approximately $74.37.

Amdocs has a market capitalization of $10.02 billion and generates $4.09 billion in revenue each year. The technology company earns $479.45 million in net income (profit) each year or $4.07 on an earnings per share basis. Amdocs employs 24,516 workers across the globe.View Additional Information About Amdocs.

The official website for Amdocs is http://www.amdocs.com/.

Amdocs' mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The technology company can be reached via phone at 1 314 212 7000 or via email at [email protected]